Sugi Predict

Sugi Predict / Compounds / SCHEMBL2004069

SCHEMBL2004069

SCHEMBL2004069

Cc1ccc2c(c1)c(C(=O)c1nc(-c3ccncn3)no1)c(Cl)n2Cc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.43
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ TP53 P04637 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ MAPT P10636 3/20 0.34
▸ PTGDR2 Q9Y5Y4 3/20 0.34
▸ AKR1B1 P15121 1/20 0.34
▸ CYP2C9 P11712 2/20 0.33
▸ SMPD1 P17405 1/20 0.33
▸ RGS12 O14924 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005916 0.93 SMPD1 (0.35) FAAHMEN1KMT2ATP53MAPT
SCHEMBL2003479 0.91 MAPT (0.36) FAAHMEN1KMT2AHTTMAPT
SCHEMBL2007239 0.90 TP53 (0.35) FAAHMEN1KMT2ATP53RXFP1
SCHEMBL2000418 0.90 MEN1 (0.43) FAAHMEN1KMT2AMAPTCYP2C9
SCHEMBL2009497 0.90 FAAH (0.41) FAAHMEN1KMT2AHTTTP53
SCHEMBL2004420 0.89 FAAH (0.44) FAAHMEN1KMT2AHTTTP53
SCHEMBL2007692 0.89 ALOX5AP (0.39) FAAHMEN1KMT2AMAPTCYP2C9
SCHEMBL2005504 0.88 FAAH (0.43) FAAHMEN1KMT2AHTTTP53
SCHEMBL2003774 0.88 CNR1 (0.38) MEN1KMT2AMAPTCYP2C9ALDH1A1
SCHEMBL2003986 0.88 TP53 (0.47) FAAHMEN1KMT2AHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 — — EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 FAAH 109/4885MEN1 3970/4885KMT2A 2233/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT FAAH 1/4885MEN1 2374/4885KMT2A 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.